Koninklijke Philips N.V. Interest Expense 2011-2026 | PHG

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Koninklijke Philips N.V.

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
288 M	288 M	277 M	235 M	159 M	173 M	196 M	188 M	222 M	342 M	344 M	-	-	-	-

All numbers in EUR currency

Indicator range from annual reports

Maximum	Minimum	Average
344 M	159 M	247 M

Interest Expense of other stocks in the Diagnostics research industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Trinity Biotech plc TRIB	6.75 M	$ 0.65	-1.84 %	$ 61.9 M	Irlanda
Centogene N.V. CNTG	8.42 M	-	-6.23 %	$ 30.6 M	Germany
Akumin AKU	118 M	-	-17.87 %	$ 25.9 M	Canada
Agilent Technologies A	81 M	$ 115.55	1.0 %	$ 35.1 B	USA
Accelerate Diagnostics AXDX	235 K	-	-61.36 %	$ 2.46 M	USA
Aspira Women's Health AWH	1.81 M	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	316 K	-	-13.05 %	$ 7.29 M	USA
Check-Cap Ltd. CHEK	13 K	-	-	$ 9.42 M	Israel
Chembio Diagnostics CEMI	2.94 K	-	0.22 %	$ 16.8 M	USA
Co-Diagnostics CODX	106 K	$ 1.67	-2.34 %	$ 2.22 M	USA
Castle Biosciences CSTL	1 K	$ 24.46	3.25 %	$ 679 M	USA
CareDx, Inc CDNA	524 K	$ 21.23	5.83 %	$ 1.13 B	USA
DermTech DMTK	-355 K	-	-11.32 %	$ 2.94 M	USA
Lantheus Holdings LNTH	31.3 M	$ 84.33	1.82 %	$ 5.69 B	USA
Enzo Biochem ENZ	494 K	-	-8.98 %	$ 14.8 K	USA
Exact Sciences Corporation EXAS	18.6 M	-	-	$ 19.8 B	USA
Fulgent Genetics FLGT	561 K	$ 16.31	1.75 %	$ 493 M	USA
Medpace Holdings MEDP	-5.34 M	$ 410.54	4.35 %	$ 11.8 B	USA
Global Cord Blood Corporation CO	6.27 M	-	-	$ 399 M	China
Genetic Technologies Limited GENE	15.2 K	-	-	$ 7.1 B	Australia
Charles River Laboratories International CRL	-22.6 M	$ 169.8	1.23 %	$ 8.42 B	USA
Guardant Health GH	-10.5 M	$ 88.91	1.18 %	$ 11.1 B	USA
HTG Molecular Diagnostics HTGM	857 K	-	-20.0 %	$ 1.06 M	USA
Heska Corporation HSKA	4.19 M	-	-	$ 1.31 B	USA
Interpace Biosciences IDXG	-252 K	$ 1.98	-2.37 %	$ 8.76 M	USA
Illumina ILMN	-292 M	$ 127.88	1.95 %	$ 20.3 B	USA
National Research Corporation NRC	-95 K	$ 17.23	-0.12 %	$ 386 M	USA
Personalis PSNL	24 K	$ 6.1	3.39 %	$ 361 M	USA
QIAGEN N.V. QGEN	-6.65 M	-	-	$ 10.6 B	Niderland
Biomerica BMRA	367	$ 2.14	-0.47 %	$ 4.92 M	USA
ICON Public Limited Company ICLR	337 M	$ 102.17	-3.92 %	$ 8.43 B	Irlanda
Laboratory Corporation of America Holdings LH	224 M	$ 263.8	-0.43 %	$ 21.9 B	USA
Motus GI Holdings MOTS	211	-	-34.28 %	$ 263 K	Israel
Celcuity CELC	2.11 M	$ 121.03	6.58 %	$ 5.66 B	USA
Thermo Fisher Scientific TMO	-12 M	$ 469.71	0.64 %	$ 177 B	USA
NeoGenomics NEO	296 K	$ 8.29	4.8 %	$ 1.06 B	USA
Neogen Corporation NEOG	38.1 M	$ 9.54	2.03 %	$ 2.07 B	USA
Twist Bioscience Corporation TWST	-903 K	$ 60.94	3.55 %	$ 3.64 B	USA
Myriad Genetics MYGN	800 K	$ 4.78	-0.21 %	$ 443 M	USA
Natera NTRA	9.32 M	$ 203.75	1.3 %	$ 20.1 B	USA
Quest Diagnostics Incorporated DGX	26 M	$ 196.27	-1.66 %	$ 21.8 B	USA
Invitae Corporation NVTA	56.7 M	-	-	$ 21.2 M	USA
Organovo Holdings ONVO	6 K	-	-2.3 %	$ 19.4 M	USA
OpGen OPGN	7.56 K	-	-16.95 %	$ 1.54 M	USA
Waters Corporation WAT	14.3 M	$ 309.87	-0.43 %	$ 18.5 B	USA